INDUSTRIES : HEALTHCARE

Healthcare PR

Today health is everyone’s business. Companies increasingly take the longview of their role in human sustainability and the environment in which their organizations operate.

The health sector is facing major challenges. Newly developed drugs, OTX products on the one hand, competition and cost pressures and drastic health policy regulations on the other. With product / brand communication (RX, OTC, DtC / specialist and public), Corporate Health and Political Communication, Social Media Healthcare, crisis communication can be successfully utilize these opportunities.

B’IMPRESS Health Practice offering includes specialties in pharmaceuticals, medical devices, health technology, life sciences & biotech, hospitals & providers, consumer health, corporate & institutional affairs, science communications, data visualization, crisis & issues management, public health & social marketing, health alliances, professional relations and education, health policy & public affairs (including market access), health media, digital health, clinical development, as well as BioScience Communications, our fullservice medical relations, education and publishing company.

Healthcare marketing is a growing field with digital and social media being one of the best ways to keep in touch and provide important information to others. It provides people with instant contact and user generated content. One of the best aspects about social media is the ability to view what others are saying and doing instantly.
One of the great parts of digital and social media is the opportunity to comment on the blog posts and read what other readers and the author have to say about it. This is useful to answering any questions and sharing ideas among others.

B’IMPRESS also works with medical device start-ups to help turn scientific studies into marketable stories. It helps company executives raise rounds of funding, build alliances and educate potential customers by communicating the exciting story behind the clinical trial – and targeting the right media. As it is sometimes suggesting to take a bigger story that cuts through the complexity and reaches broader audiences.

In addition, digital diagnostics and therapy offerings are entering the market and analog products such as medicines and services will increasingly merge with digital offerings in the coming years. This has been the case for pharmaceuticals since 2011 (AMNOG), for digital health applications (DiPA) since 2020 (DVG) and now also for DiPA (DVPMG): Access to the statutory health insurance (SHI) benefits catalog and pricing are linked to the ability to demonstrate benefits (see MDR) and additional benefits in accordance with the principles of evidence-based medicine.

How can you optimally bring the effect of your products to market throughout their entire life cycle? How can you also use new fields of innovation such as “companion” and “beyond the pill” approaches to optimize efficacy and benefits? How do you design the path to your hybrid portfolio of medicinal products, digital and analog offerings?

With market analyses of the product portfolio or your studies, support through the benefit assessment, the policy impact assessment for your products, healthcare research and the preparation of healthcare reports as well as health economic models and professional communication to stakeholders, we are happy to accompany you along the entire lifecycle of your products. And we advise you on the best possible combination of your portfolio with an intelligent digital strategy and the digitalization of the healthcare system with ePA, DiGA, DiPA and so on. And last but not least, we support you in the market access of your healthcare-related products with business development and social media.